Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-37 Cr₹76 Cr₹19 Cr₹155 Cr₹-93 Cr

What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?

The latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA is ₹-37 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-37 Cr
Mar2024₹76 Cr
Mar2023₹19 Cr
Mar2022₹155 Cr
Mar2021₹-93 Cr

How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-37 Cr
Negative
Mar2024 ₹76 Cr
290.95
Mar2023 ₹19 Cr
-87.48
Mar2022 ₹155 Cr
Positive
Mar2021 ₹-93 Cr -

Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,642.9 Cr -2% 2.7% 7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹449,299.0 Cr 0.5% 1.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹174,207.0 Cr -3.3% -3.5% 1.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,721.0 Cr 4.5% 2.6% 42.6% Stock Analytics
CIPLA ₹117,420.0 Cr 2.7% 2.5% -4% Stock Analytics
DR REDDYS LABORATORIES ₹114,876.0 Cr 6.6% 4.3% 1.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2%

2.7%

7.5%

SENSEX

-0.1%

1%

-5.7%


You may also like the below Video Courses